Clovis Oncology Inc (NASDAQ:CLVS)
| 7.45 BATS BZX Real-Time Price As of 10:13am ET |  +0.77 / +11.53%Today’s Change | 3.62 Today|||52-Week Range 11.63 | +55.21% Year-to-Date |
Latest CLVS News | Press Releases
No recent news for Clovis Oncology Inc.
Today’s Trading
| Previous close | 6.68 |
| Today’s open | 6.30 |
| Day’s range | 6.75 - 7.46 |
| Volume | 97,827 |
| Average volume (3 months) | 4,962,801 |
| Market cap | $556.4M |
Data as of 10:13am ET, 01/25/2021
Growth & Valuation
| Earnings growth (last year) | -5.16% |
| Earnings growth (this year) | +46.70% |
| Earnings growth (next 5 years) | +50.71% |
| Revenue growth (last year) | +49.92% |
| P/E ratio | NM |
| Price/Sales | 3.93 |
| Price/Book | -- |
Competitors
| ---- | ||
| EPIXESSA Pharma Inc | -0.20 | -1.10% |
| SPPISpectrum Pharmaceuti... | -0.02 | -0.50% |
| ORTXOrchard Therapeutics... | +0.26 | +4.39% |
Data as of 10:13am ET, 01/25/2021
Financials
| Next reporting date | February 23, 2021 |
| EPS forecast (this quarter) | -$0.76 |
| Annual revenue (last year) | $143.0M |
| Annual profit (last year) | -$400.4M |
| Net profit margin | -280.01% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
